Egybort – Bortezomib Injection
Description
BORTEZOMIB (EGYBORT) INJECTION – TREATMENT OF NUMEROUS MYELOMA AND MANTLE-CELL LYMPHOMA
Bortezomib 3.5 mg is used to treat multiple myeloma and mantle cell lymphoma. It works by preventing or slowing the growth of abnormal cells.
How is Bortezomib 3.5mg used?
Bortezomib 3.5mg is administered intravenously by a certified clinical professional. Your PCP will determine which portion is a mainstay and how frequently you should consume it. This will vary depending on the situation and may change from time to time. You should take it exactly as prescribed by your doctor. Misinterpretation or excessive consumption might have serious repercussions.
Side effects of this injection
The chief side effects of this medication are weakness, nausea, retching, and loss of appetite. During therapy, you may be instructed to consume enough of fluids at all times. Because the medications may cause sleepiness and instability, you should not drive or operate machinery. This medicine may reduce the number of platelets in the blood (poor red blood and white platelets), thereby extending weakness into illness.
If you have any liver, renal, or coronary artery disease, or if you have a drainage problem, consult your primary care physician before receiving the injection. If symptoms such as cognitive decline or disturbed thinking arise, it is vital to visit a doctor.
